New forms of Maxigesic coming
AFT Pharmaceuticals will be commencing regulatory filings for new forms of Maxigesic in 2019 including an intravenous version for hospital use and an oral liquid for children.
Additional dose forms, hot drink sachets and dry stick sachets, are also in development with regulatory filings expected to commence in 2019.
Learn more about Maxigesic in the QCPP education module shown below.
Source: extract from Pharmacydaily.com.au, Friday 23 November 2018